VANCOUVER, BC, Sept. 7, 2021 /PRNewswire/ -- InMed
Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq:
INM), a leader in the manufacturing and development of rare
cannabinoids, announced that Eric. A. Adams, President and CEO
of InMed, will present live at VirtualInvestorConferences.com on
September 8, 2021.
DATE: September 8th,
2021
TIME: 1:30 PM
ET
LINK: https://bit.ly/3ylJi2m
This will be a live, interactive online event where investors
are invited to ask the company questions in real-time. If attendees
are not able to join the event live on the day of the conference,
an archived webcast will also be made available after the
event.
It is recommended that investors pre-register and run the online
system check to expedite participation and receive event
updates.
Learn more about the event at
www.virtualinvestorconferences.com.
Recent Company Highlights:
- InMed increased the yield of their proprietary IntegraSyn™ rare
cannabinoid manufacturing approach to 5 g/L, further improving the
overall economics in advance of commercial scale production.
- InMed's rare cannabinoid yield of 5 g/L significantly exceeds
currently reported industry yields, further validating the
IntegraSyn™ manufacturing approach as a commercially viable
solution for large-scale, pharmaceutical-grade GMP production of
rare cannabinoids.
- InMed announced a non-binding letter of intent to acquire
BayMedica, a private company based in Nevada and California that specializes in the manufacture
and commercialization of rare cannabinoids.
- InMed has filed clinical trial applications in several
countries as part of a Phase 2 Clinical Trial to evaluate INM-755
(cannabinol) cream for the treatment of Epidermolysis Bullosa.
About InMed
InMed Pharmaceuticals is a clinical-stage company developing a
pipeline of cannabinoid-based pharmaceutical drug candidates,
initially focused on the therapeutic benefits of cannabinol ("CBN")
and is developing IntegraSyn™ to produce pharmaceutical-grade
cannabinoids. The Company is dedicated to delivering new
therapeutic alternatives to patients that may benefit from
cannabinoid-based pharmaceutical drugs. For more information,
visit www.inmedpharma.com.
About Virtual Investor
Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary
investor conference series that provides an interactive forum for
publicly-traded companies to meet and present directly with
investors.
A real-time solution for investor engagement, Virtual Investor
Conferences is part of OTC Market Group's suite of investor
relations services specifically designed for more efficient
Investor Access. Replicating the look and feel of on-site
investor conferences, Virtual Investor Conferences combine
leading-edge conferencing and investor communications capabilities
with a comprehensive global investor audience network.
Cautionary Note Regarding Forward-Looking
Information:
This news release contains "forward-looking information" and
"forward-looking statements" (collectively, "forward-looking
information") within the meaning of applicable securities laws.
Forward-looking information is based on management's current
expectations and beliefs and is subject to a number of risks and
uncertainties that could cause actual results to differ materially
from those described in the forward-looking statements.
Forward-looking information in this news release includes
statements about: presenting present live at the Virtual Investor
Conferences on September 8, 2021;
delivering new therapeutic alternatives to patients that may
benefit from cannabinoid-based pharmaceutical drugs; advancing
IntegraSyn™ to commercial scale production;
IntegraSyn™ being a commercially viable solution for
large-scale, pharmaceutical-grade GMP production of rare
cannabinoids; and developing a pipeline of cannabinoid-based
pharmaceutical drug candidates. All forward-looking information
herein is qualified in its entirety by this cautionary statement,
and InMed disclaims any obligation to revise or update any such
forward-looking information or to publicly announce the result of
any revisions to any of the forward-looking information contained
herein to reflect future results, events or developments, except as
required by law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inmed-pharmaceuticals-to-webcast-live-at-virtualinvestorconferencescom-september-8th-301370678.html
SOURCE VirtualInvestorConferences.com